Purification, cloning and characterization of a metalloproteinase from Naja atra venom

Toxicon

Volumn 56, Issue 8, 2010, Pages 1459-1469

  Sun, Qian Yun ^a   Bao, Juan ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Cobra venom; Complement; Complement inhibition; Fibrinogenase; Metalloproteinase

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ATRASE B; AZOCASEIN; BENZOYLARGININE ETHYL ESTER; CASEIN; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENTARY DNA; FIBRIN; FIBRINOGEN; METALLOPROTEINASE; SNAKE VENOM; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BLEEDING; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; EDEMA; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; ISOELECTRIC POINT; MOLECULAR CLONING; MOLECULAR WEIGHT; NAJA ATRA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; SEQUENCE HOMOLOGY; SNAKE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CLONING, MOLECULAR; COBRA; COBRA VENOMS; COMPLEMENT INACTIVATING AGENTS; COMPLEMENT SYSTEM PROTEINS; HUMANS; METALLOPROTEASES; MOLECULAR SEQUENCE DATA; TOXICITY TESTS;

NAJA ATRA;

EID: 77958462138     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.08.013     Document Type: Article

References (44)

1. Bajwa S.S., Markland F.S., Russell F.E. Fibrinolytic enzyme(s) in western diamondback rattlesnake (Crotalus atrox) venom. Toxicon 1980, 18:285-290.
2. Ballow M., Cochrane C.G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J. Immunol. 1969, 103:944-952.
3. Chen T., Rael E.D. Purification of M5, a fibrinolytic proteinase from Crotalus molossus molossus venom that attacks complement. Int. J. Biochem. Cell Biol. 1997, 29:789-799.
4. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956, 28:350-356.
5. Eggertsen G., Fohlman J., Sjöquist J. In vitro studies on complement inactivation by snake venoms. Toxicon 1980, 18:87-96.
6. Evans H.J. Purification and properties of a fibrinogenase from the venom of Naja nigricollis. Biochim. Biophys. Acta 1984, 802:49-54.
7. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 1996, 272:50-53.
8. Fox J.W., Serrano S.M.T. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 2005, 45:969-985.
9. Gasmi A., Louzir H., Karoui H., Ayeb M., Dellagi K. Purification from Vipera lebetina (desert adder) venom of a protein that depletes human complement. Nat. Toxins 1994, 2:44-48.
10. Glossmann H., Neville D.M. Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J. Biol. Chem. 1971, 246:6339-6346.
11. Guan H.H., Goh K.S., Davamani F., Wu P.L., Huang Y.W., Jeyakanthan J., Wu W.G., Chen C.J. Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADAMalysin family proteins. J. Struct. Biol. 2010, 169:294-303.
12. Guo X.X., Zeng L., Lee W.H., Zhang Y., Jin Y. Isolation and cloning of a metalloproteinase from king cobra snake venom. Toxicon 2007, 49:954-965.
13. Gutiérrez J.M., Romero M., Díaz C., Borkow G., Ovadia M. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 1995, 33:19-29.
14. Holers V.M. The spectrum of complement alternative pathway-mediated diseases. Immunol. Rev. 2008, 223:300-316.
15. Holers V.M., Thurman J.M. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol. Immunol. 2004, 41:147-152.
16. Ito M., Hamako J., Sakurai Y., Matsumoto M., Fujimura Y., Suzuki M., Hashimoto K., Titani K., Matsui T. Complete amino acid sequence of kaouthiagin, a novel cobra venom metalloproteinase with two disintegrin-like sequences. Biochemistry 2001, 40:4503-4511.
17. Jagadeesha D.K., Shashidhara Murthy R., Girish K.S., Kemparaju K. A non-toxic anticoagulant metalloprotease: purification and characterization from India cobra (Naja naja naja) venom. Toxicon 2002, 40:667-675.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Le G.T., Abbenante G., Fairlie D.P. Profiling the enzymatic properties and inhibition of human complement factor B. J. Biol. Chem. 2007, 282:34809-34816.
20. Man D.P., Minta J.O. Purification, characterization and analysis of the mechanism of action of four anti-complementary factors in Crotalus atrox venom. Immunochemistry 1977, 14:521-527.
21. Matsumoto M., Fukuda W., Circolo A., Goellner J., Strauss-Schoenberger J., Wang X., Fujita S., Hidvegi T., Chaplin D.D., Colten H.R. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 1997, 94:8720-8725.
22. Molina O., Seriel R.K., Martinez M., Sierra M.L., Varela-Ramirez A., Rael E.D. Isolation of two hemorrhagic toxins from Crotalus basiliscus basiliscus (Mexican west coast rattlesnake) venom and their effect on blood clotting and complement. Int. J. Biochem. 1990, 22:253-261.
23. Mollnes T.E., Kirschfink M. Strategies of therapeutic complement inhibition. Mol. Immunol. 2006, 43:107-121.
24. O'Keefe M.C., Caporale L.H., Vogel C.W. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol. Chem. 1988, 263:12690-12697.
25. Ouyang C., Teng C.M. Fibrinogenolytic enzymes of Trimeresurus mucrosquamatus venom. Biochim. Biophys. Acta 1976, 420:298-308.
26. Ownby C.L., Bjarnason J., Tu A.T. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom. Pathogenesis of hemorrhage induced by three purified toxins. Am. J. Pathol. 1978, 93:201-210.
27. Retzios A.D., Markland F.S. Purification, characterization, and fibrinogen cleavage sites of three fibrinolytic enzymes from the venom of Crotalus basiliscus basiliscus. Biochemistry 1992, 31:4547-4557.
28. Robertson E.F., Dannelly H.K., Malloy P.J., Reeves H.C. Rapid isoelectric focusing in a vertical polyacrylamide minigel system. Anal. Biochem. 1987, 167:290-294.
29. Roozendaal R., Carroll M.C. Emerging patterns in complement-mediated pathogen recognition. Cell 2006, 125:29-32.
30. Schmidt B.Z., Colten H.R. Complement: a critical test of its biological importance. Immunol. Rev. 2000, 178:166-176.
31. Shoibonov B.B., Osipov A.V., Kryukova E.V., Zinchenko A.A., Lakhtin V.M., Tsetlin V.I., Utkin Y.N. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement. Mol. Immunol. 2005, 42:1141-1153.
32. Steckel E.W., York R.G., Monahan J.B., Sodetz J.M. The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure. J. Biol. Chem. 1980, 255:11997-12005.
33. Sun Q.Y., Li M., Yang F.M. Purification and characterization of a metalloproteinase with weak fibrinogenolytic activity from Naja atra venom. Chin. J. Biochem. Mol. Biol. 2007, 23:835-843.
34. Sunyer J.O., Lambris J.D. Evolution and diversity of the complement system of poikilothermic vertebrates. Immunol. Rev. 1998, 166:39-57.
35. Thurman J.M., Holers V.M. The central role of the alternative complement pathway in human disease. J. Immunol. 2006, 176:1305-1310.
36. Trikha M., Schmitmeier S., Markland F.S. Purification and characterization of fibrolase isoforms from venom of individual southern copperhead (Agkistrodon contortrix contortrix) snakes. Toxicon 1994, 32:1521-1531.
37. Tu A.T., Toom P.M., Ganthavorn S. Hemorrhagic and proteolytic activities of Thailand snake venoms. Biochem. Pharmacol. 1967, 16:2125-2130.
38. von Zabern I., Przyklenk H., Damerau B., Zimmermann B. Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom. Scand. J. Immunol. 1981, 14:109-120.
39. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
40. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
41. Ward C.M., Vinogradov D.V., Andrews R.K., Berndt M.C. Characterization of mocarhagin, a cobra venom metalloproteinase from Naja mocambique mocambique, and related proteins from other elapidae venoms. Toxicon 1996, 34:1203-1206.
42. Wei J.F., Mo Y.Z., Qiao L.Y., Wei X.L., Chen H.Q., Xie H., Fu Y.L., Wang W.Y., Xiong Y.L., He S.H. Potent histamine-releasing activity of atrahagin, a novel snake venom metalloproteinase. Int. J. Biochem. Cell Biol. 2006, 38:510-520.
43. Yamamoto C., Tsuru D., Oda-Ueda N., Ohno M., Hattori S., Kim S.T. Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase. Immunology 2002, 107:111-117.
44. Zhu Z.G., Wu S.G. Fibrinogenolytic properties of natrahagin (a proteinase from cobra venom) and its effect on human platelet aggregation. Acta Pharmacol. Sin. 1999, 20:944-947.